The most active researchers, institutions, and subtopics in Chronic Lymphocytic Leukemia, from recent PubMed records. Public authorship only, every figure verifiable by PMID.
Analyzed 598 recent PubMed papers (2021-2026) matching "chronic lymphocytic leukemia treatment BTK inhibitor". Source: NLM PubMed. Generated July 2026.
| # | Researcher | Affiliation | Papers |
|---|---|---|---|
| 1 | Ghia Paolo | Università Vita-Salute San Raffaele | 23 |
| 2 | Shadman Mazyar | Clinical Research Division | 23 |
| 3 | Robak Tadeusz | Medical University of Lodz | 20 |
| 4 | Jurczak Wojciech | Maria Sklodowska-Curie National Research Institute of Onco | 14 |
| 5 | Molica Stefano | Hull University Teaching Hospitals NHS Trust | 13 |
| 6 | Stilgenbauer Stephan | Ulm University | 13 |
| 7 | Visentin Andrea | University of Padua | 12 |
| 8 | Jain Nitin | The University of Texas MD Anderson Cancer Center | 12 |
| 9 | Lamanna Nicole | Columbia University | 12 |
| 10 | Munir Talha | Leeds Teaching Hospitals NHS Trust | 11 |
| 11 | Ma Shuo | Northwestern University | 11 |
| 12 | Sun Clare | Hematology Branch | 11 |
| 13 | Scarfò Lydia | IRCCS Ospedale San Raffaele | 10 |
| 14 | Hallek Michael | University of Cologne | 10 |
| 15 | Gaidano Gianluca | Università del Piemonte Orientale and Azienda Ospedaliero- | 10 |
| 16 | Wiestner Adrian | Hematology Branch | 10 |
| 17 | Ferrajoli Alessandra | The University of Texas MD Anderson Cancer Center | 9 |
| 18 | Qiu Lugui | National Clinical Research Center for Blood Diseases | 9 |
Ranked by recent publication volume; names not yet disambiguated and not citation-weighted. The full brief adds ORCID disambiguation, citation weighting, and clinical-trial investigator data.
Recurrent Granulomatous Panuveitis and Sarcoidosis-Like Reaction Associated with Bruton Tyrosine Kinase Inhibitors in Chronic Lymp (2026) · PMID 42462146
Safety and Management of Targeted Therapies for Relapsed/Refractory Chronic Lymphocytic Leukemia. (2026) · PMID 42458174
HS1 loss drives cytoskeletal dysregulation and reduces sensitivity to BTK inhibition in chronic lymphocytic leukemia. (2026) · PMID 42454958
Polypharmacy in Chronic Lymphocytic Leukemia in the Era of Targeted Agents: A Medication Stewardship Perspective. (2026) · PMID 42437563
Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic ly (2026) · PMID 42425121
A full Chronic Lymphocytic Leukemia brief adds citation weighting, name disambiguation, clinical-trial investigators, and a cited PDF, scoped to your exact molecule, competitor set, or region.